Target intelligence / Profile preview

Diverse pathogen and autoantigen epitopes

Molecular classification
Other
01

Overview

Diverse pathogen and autoantigen epitopes refer to the specific molecular regions of antigens—derived from either external infectious agents or internal self-proteins—that are recognized by the adaptive immune system's B-cell and T-cell receptors (Janeway's Immunobiology, 9th ed.). Pathogen-derived epitopes are critical components in the design of vaccines and diagnostic assays, as they elicit protective immune responses against viruses, bacteria, and parasites (NCBI Bookshelf, Immunobiology). Conversely, autoantigen epitopes are the targets of aberrant immune responses in autoimmune diseases, where the immune system fails to distinguish between self and non-self (PubMed, PMID: 30236505). In a therapeutic context, these epitopes are not single targets but rather a broad class of structural motifs used to engineer immunotherapies, including monoclonal antibodies and epitope-based vaccines (Nature Reviews Drug Discovery, 2020). The diversity of these sequences necessitates precise mapping to avoid off-target effects such as cross-reactivity or the induction of unintended inflammatory cascades. Because this entry represents a diverse collection of molecular fragments rather than a single protein or receptor, it does not function as a discrete therapeutic target but rather as a category of immunological triggers.

Other names
Antigenic determinantsB-cell epitopesT-cell epitopesImmunodominant regionsPeptide epitopes
02

Mechanism of action

Epitopes serve as the specific recognition sites for antibodies and T-cell receptors, triggering immune activation, neutralization of pathogens, or, in the case of autoantigens, the breakdown of self-tolerance.

03

Biological functions

Immune responseAntigen presentationImmune recognition
04

Disease associations

InfectionInflammationAutoimmune diseaseCancer
05

Safety considerations

Molecular mimicryCross-reactivityAutoimmunityCytokine release syndromeAnaphylaxis
06

Interacting drugs

Vaccines

3 more in the full profile.

07

Biomarkers

Antibody titersT-cell activation markersELISpot assaysMHC-peptide multimer binding

Beyond the preview

Go deeper on Diverse pathogen and autoantigen epitopes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diverse pathogen and autoantigen epitopes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call